Volume 21, Number 3—March 2015
Dispatch
Reemergence of Murine Typhus in Galveston, Texas, USA, 2013
Table 1
Patient no. | Illness duration† | Acute titer (date collected) | Convalescent titer (date collected) | Diagnosis by case definition |
---|---|---|---|---|
1 | 12 d | 256 (Apr 10) | 1,024 (Apr 30) | Confirmed |
4‡ | 4 d | NR (May 23) | NA | Confirmed |
6 | 4 d | NR (Jun 16) | 128 (Jul 2) | Confirmed |
8 | 7 d | NR (Jul 10) | 512 (Aug 8) | Confirmed |
9 | 10 d | NR (Jul 16) | 256 (Jul 30) | Confirmed |
10 | 13 d | NR (Jul 19) | 256 (Jul 30) | Confirmed |
17 | 6 d | NR (Sep 27) | 1,024 (Dec 13) | Confirmed |
13 | 8 d | 256 (Jul 29) | NA | Probable |
15 | 8 d | 256 (Aug 9) | NA | Probable |
16§ | 3 wk¶ | 256 (Jul 30) | NA | Probable |
19 | 3 wk | 512 (Oct 30) | NA | Probable |
20§ | 8 d | 256 (Mar 26) | NA | Probable |
*NR, nonreactive at a titer of 1:64; NA, not available.
†Duration of illness before workup and treatment.
‡Confirmed by culture isolate.
§Case identified retrospectively.
¶Patient was treated with levofloxacin 2 weeks before murine typhus workup.
Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.